- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01692574
Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD) (TODI)
August 18, 2016 updated by: University of Pennsylvania
Treatment of Obesity in Depressed Individuals: A Randomized Controlled Trial
To determine whether individuals who suffer from depression and obesity are able to lose weight and show improvements in mood and cardiovascular disease risk factors following 20 weeks of a combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss.
Participants will be assigned to one of three treatments: 1) cognitive-behavior therapy for the treatment of depression combined with an alternative approach to weight loss, 2) a weight loss intervention combined with a depression support and education , or 3) cognitive-behavioral therapy for depression combined with a weight loss intervention.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
76
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania: Center for Weight and Eating Disorders
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria
- Female and male participants, with a BMI of 27 kg/m2 to 45 kg/m2
- Age 18 - 70 years old
- Presence of current major depressive disorder or dysthymic disorder
At least 2 CVD risk factors, as characterized by the metabolic syndrome, including:
- Elevated waist circumference (males 40 inches or 102 cm; females 35 inches of 88 cm)
- Fasting blood glucose 100 mg/dL
- Blood pressure 130/85 mm Hg
- Triglycerides 150 mg/dL
- Reduced HDL cholesterol (males 40 mg/dL; females 50 mg/dL)
- OR medications for these conditions
- Able to comply will all study procedures and schedule
- Able to speak and read English
Exclusion Criteria
- Cardiovascular event (e.g., myocardial infarction, stroke) within the past 12 months
- Use of tricyclic anti-depressants, monoamine oxidase inhibitors or paroxetine, mood stabilizers, or antipsychotic medications. (Note: participants who take SSRI/SNRI may be acceptable, provided they have been on a stable dose of these medications 3 months.)
- Use of weight-loss medications or any medications known to significantly affect weight (e.g., oral steroids) in past 3 months
- Weight loss of 5% or more in past 6 months
- Enrollment in weight reduction program in prior 3 months
- Treatment in individual psychotherapy for any psychiatric disorder in prior 3 months (Note: participants in couples or family counseling will be allowed.)
- Severe depression or severe impairment of functioning as judged by the assessor or PI
- Presence of active suicidal ideation
- Diabetes
- Alcohol/drug abuse/dependence
- Renal/hepatic disease
- Change in thyroid medications in last 3 months
- Pregnant/lactating, within 6-months post-partum
- Current diagnoses, or history within the last 5 years, of anorexia or bulimia
- Psychotic symptoms or hospitalization for a psychiatric disorder in previous 12 months
- Mood disorder NOS, substance-induced mood disorders, mood disorders due to a general medical condition
- History of bipolar disorder
- History of head trauma
- Any changes in smoking behavior in prior 3 months (or plans to change in the next 3 months)
- Plans for bariatric surgery
- Any other uncontrolled major medical problems
- Women who are pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Combined
Group cognitive-behavior therapy for depression combined with behavior modification for weight loss
|
|
Active Comparator: GCBT-ND
Group cognitive-behavior therapy for depression combined with an alternative approach to weight loss
|
|
Active Comparator: DSE
Behavior modification for weight loss combined with depression support and education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight loss
Time Frame: Baseline to 20 weeks of treatment, follow-up at week 46
|
To determine whether depressed, obese individuals who receive the combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss are able to lose 5% of their initial weight at the end of 20 weeks of treatment.
|
Baseline to 20 weeks of treatment, follow-up at week 46
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in metabolic cardiovascular disease risk factors and inflammatory markers
Time Frame: Baseline to 20 weeks of treatment, follow up at week 46
|
Baseline to 20 weeks of treatment, follow up at week 46
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in mood
Time Frame: Baseline to 20 weeks of treatment, follow up at week 46
|
Baseline to 20 weeks of treatment, follow up at week 46
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lucy F Hemsley-Faulconbridge, PhD, University of Pennsylvania Center for Weight and Eating Disorders
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
September 20, 2012
First Submitted That Met QC Criteria
September 20, 2012
First Posted (Estimate)
September 25, 2012
Study Record Updates
Last Update Posted (Estimate)
August 22, 2016
Last Update Submitted That Met QC Criteria
August 18, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 813829
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Behavior Modification for Weight Loss
-
University of VermontCompletedObesity | Weight Loss | Diet TherapyUnited States
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office...CompletedObesity | Overweight | Weight Loss | Overweight and ObesityUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Drexel UniversityCompletedObesity | Overweight | Weight LossUnited States
-
Noom Inc.CompletedObesity | Weight Loss | Overweight and Obesity | Self Efficacy | Behavior, Health | Behavior, EatingUnited States
-
Noom Inc.CompletedObesity | Weight Loss | Overweight and Obesity | Overweight or Obesity | Eating Behavior | Food Habits | Eating Disorder SymptomUnited States
-
Drexel UniversityCompletedObesity | Overweight | Weight LossUnited States
-
Noom Inc.CompletedObesity | Weight Loss | Behavior, HealthUnited States
-
Kaiser PermanenteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed